17,155 Shares of Phibro Animal Health Corporation $PAHC Bought by Kings Path Partners LLC

Kings Path Partners LLC acquired a new stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) in the 3rd quarter, HoldingsChannel.com reports. The fund acquired 17,155 shares of the company’s stock, valued at approximately $613,000.

Several other hedge funds also recently made changes to their positions in the business. KBC Group NV bought a new stake in shares of Phibro Animal Health in the 1st quarter worth approximately $29,000. Inspire Investing LLC acquired a new stake in Phibro Animal Health during the first quarter valued at approximately $158,000. Sanctuary Advisors LLC acquired a new stake in Phibro Animal Health during the first quarter valued at approximately $247,000. Fifth Third Bancorp lifted its stake in Phibro Animal Health by 2,050.0% during the first quarter. Fifth Third Bancorp now owns 4,558 shares of the company’s stock valued at $252,000 after purchasing an additional 4,346 shares during the last quarter. Finally, Pictet Asset Management Holding SA bought a new stake in Phibro Animal Health during the first quarter worth approximately $258,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on PAHC. Weiss Ratings restated a “hold (c+)” rating on shares of Phibro Animal Health in a report on Friday, September 11th. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Friday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $47.67.

Phibro Animal Health Trading Up 1.2%

Shares of NASDAQ PAHC opened at $39.25 on Thursday. Phibro Animal Health Corporation has a 12 month low of $28.25 and a 12 month high of $60.08. The company has a market cap of $1.59 billion, a price-to-earnings ratio of 12.09, a P/E/G ratio of 1.12 and a beta of 0.42. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84. The business has a fifty day simple moving average of $36.49 and a 200-day simple moving average of $38.05.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.14. The business had revenue of $396.75 million during the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Sell-side analysts predict that Phibro Animal Health Corporation will post 3.49 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, September 2nd. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. Phibro Animal Health’s dividend payout ratio is currently 19.67%.

Phibro Animal Health Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.